Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

Capecitabine (CAP) is a 5-FU pro-drug approved for the treatment of several cancers and it is used in combination with gemcitabine (GEM) in the treatment of patients with pancreatic adenocarcinoma (PDAC). However, limited pre-clinical data of the effects of CAP in PDAC are available to support the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Courtin, Aurélie, Richards, Frances M., Bapiro, Tashinga E., Bramhall, Jo L., Neesse, Albrecht, Cook, Natalie, Krippendorff, Ben-Fillippo, Tuveson, David A., Jodrell, Duncan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696095/
https://www.ncbi.nlm.nih.gov/pubmed/23840665
http://dx.doi.org/10.1371/journal.pone.0067330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696095/
https://www.ncbi.nlm.nih.gov/pubmed/23840665
http://dx.doi.org/10.1371/journal.pone.0067330

Ejemplares similares